Sign in
4

Changes in Ownership

Vaxcyte, Inc. Filed Acc 0001649094-24-000021

CHIEF EXECUTIVE OFFICER sold 15,000 shares at an average $75.64 ($1,134,579)

  • CHIEF EXECUTIVE OFFICER acquired 15,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

PICKERING GRANT · CHIEF EXECUTIVE OFFICER

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-06-24 Exercise or conversion : show line 1 in the form 10b5-1 +15,000 $2.03 $30,450 493,888 D
2024-06-24 Sale : show line 2 in the form 10b5-1 −10,341 $75.39 $779,577 483,547 D
2024-06-24 Sale : show line 3 in the form 10b5-1 −4,471 $76.17 $340,565 479,076 D
2024-06-24 Sale : show line 4 in the form 10b5-1 −188 $76.80 $14,437 478,888 D
Open-market sales · 15,000 sh · avg $75.64 · $1,134,579

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-06-24 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (right to buy) +15,000 197,327 D
Loading xslF345X05/wk-form4_1719348224.xml…